ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,822Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 457

$858K Total Retail Price of All Prescriptions

Rank: 62 out of 457

334 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 12,503 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 658 613 1 1
VOLTAREN 450 401 2 34
CRESTOR 399 360 3 9
NEXIUM 385 329 4 12
IBUPROFEN 385 322 4 14
DICLOFENAC SODIUM 319 295 6 49
LISINOPRIL 285 282 7 3
CELEBREX 271 241 8 53
LIDODERM 260 216 9 31
NAPROXEN 255 227 10 65
RANITIDINE HCL 250 233 11 17
ZOLPIDEM TARTRATE 238 219 12 13
CILOSTAZOL 235 231 13 88
AMLODIPINE BESYLATE 233 228 14 4
SIMVASTATIN 230 217 15 2
ATENOLOL 226 214 16 11
METFORMIN HCL 216 200 17 6
AZITHROMYCIN 213 177 18 44
DEXILANT 211 185 19 118
LYRICA 208 190 20 77
DIOVAN 195 166 21 30
METOPROLOL TARTRATE 194 184 22 7
DONEPEZIL HCL 176 172 23 22
FUROSEMIDE 175 172 24 10
PATANASE 174 155 10 25 333
LEVOTHYROXINE SODIUM 172 166 26 5
AMMONIUM LACTATE 169 154 27 82
PENTOXIFYLLINE 163 149 28 67
NASONEX 161 148 29 129
ESCITALOPRAM OXALATE 141 136 30 61
HYDROCHLOROTHIAZIDE 138 136 31 8
CIPROFLOXACIN HCL 138 120 31 71
FLUTICASONE PROPIONATE 137 120 33 40
CLOTRIMAZOLE-BETAMETHASONE 135 114 34 60
NYSTATIN-TRIAMCINOLONE 127 118 35 200
PROCTOZONE-HC 123 114 36 193
CIPRODEX 122 93 37 369
CLOPIDOGREL 120 109 38 19
FEXOFENADINE HCL 120 117 38 269
MUPIROCIN 117 87 40 91
LACTULOSE 116 106 41 78
GLYBURIDE-METFORMIN HCL 111 89 R 42 70
GLYBURIDE 94 80 R 43 64
TRIAMCINOLONE ACETONIDE 93 85 44 132
SINGULAIR 92 75 45 43
CYCLOBENZAPRINE HCL 91 72 R 46 99
KETOCONAZOLE 89 70 47 92
NAMENDA 87 79 48 32
ENALAPRIL MALEATE 84 84 49 35
LEVOFLOXACIN 81 77 50 131
MECLIZINE HCL 80 76 51 55
PLAVIX 79 79 52 24
DICYCLOMINE HCL 78 78 53 115
ZENPEP 77 77 54 246
CARVEDILOL 75 66 55 20
GLIPIZIDE 74 74 56 42
DIOVAN HCT 71 69 57 51
ADVAIR DISKUS 69 47 58 27
HYDROCODONE-ACETAMINOPHEN 68 41 S3 59 23
POTASSIUM CHLORIDE 66 66 60 28
MONTELUKAST SODIUM 62 44 61 86
IBANDRONATE SODIUM 60 59 62 183
PAROXETINE HCL 60 60 62 68
PROAIR HFA 59 51 64 66
ALENDRONATE SODIUM 58 58 65 16
TAMSULOSIN HCL 57 57 66 36
LEXAPRO 56 56 67 138
PROCTOSOL-HC 55 55 68 300
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.